Advances in treating psoriasis in the elderly with small molecule inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Advances in treating psoriasis in the elderly with small molecule inhibitors

Published:2017-11-27 Issue:18 Volume:18 Page:1965-1973
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Cline Abigail¹,Cardwell Leah A.²,Feldman Steven R.²³⁴

Affiliation:

1. Department of Internal Medicine, Augusta University Medical Center, Augusta, Georgia

2. Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA

3. Department of Pathology, Wake Forest School of Medicine, Winston-Salem, NC, USA

4. Department of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2017.1409205

Reference68 articles.

1. Psoriasis prevalence among adults in the United States

2. Psoriasis in the elderly: From the Medical Board of the National Psoriasis Foundation

3. The Safety of Systemic Treatments That Can Be Used for Geriatric Psoriasis Patients: A Review

4. Managing Moderate-to-Severe Psoriasis in the Elderly

5. Risk of Serious Adverse Events Associated With Biologic and Nonbiologic Psoriasis Systemic Therapy

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small Molecules in the Management of Psoriasis and Psoriatic Arthritis;Indian Journal of Dermatology;2024-05

2. Use of systemic Janus kinase inhibitors for dermatologic indications in the elderly: A retrospective study of 67 cases;Journal of the American Academy of Dermatology;2023-12

3. Current and emerging prospects in the psoriatic treatment;International Immunopharmacology;2023-07

4. Oral small-molecule tyrosine kinase 2 and phosphodiesterase 4 inhibitors in plaque psoriasis: a network meta-analysis;Frontiers in Immunology;2023-06-02

5. Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part II: focus on elderly patients;Expert Opinion on Drug Safety;2023-01-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3